Klinisch orientierter Schwerpunkt
FB 04 - Universitätsmedizin / Johannes Gutenberg-Universität Mainz
Helmig, S.; Bender, K.; Tug, S. et al.
Exercise-induced cell free DNA in human plasma is predominantly released from cells of the haematopoietic lineageACTA PHYSIOLOGICA. Bd. 216. 2016
Alt, Y.; Schattenberg, J. M.
Expected increase of hepatocellular carcinoma by nonalcoholic fatty liver diseaseZEITSCHRIFT FUR GASTROENTEROLOGIE. Bd. 54. H. 4. 2016 S. 364-365
Schwentner, Lukas; Van Ewijk, Reyn; Kuehn, Thorsten et al.
Exploring patient- and physician-related factors preventing breast cancer patients from guideline-adherent adjuvant chemotherapy-results from the prospective multi-center study BRENDA IISUPPORTIVE CARE IN CANCER. Bd. 24. H. 6. 2016 S. 2759-2766
Galle, Peter Robert
Extended Abstract: Management of Liver CancerDIGESTIVE DISEASES. Bd. 34. H. 4. 2016 S. 438-439
Schattenberg, Joern M.; Lee, Myung-Shik
Extracellular Vesicles as Messengers Between Hepatocytes and Macrophages in Nonalcoholic SteatohepatitisGASTROENTEROLOGY. Bd. 150. H. 4. 2016 S. 815-818
Koch-Gallenkamp, Lena; Bertram, Heike; Eberle, Andrea et al.
Fear of Recurrence in Long-Term Cancer Survivors-Do Cancer Type, Sex, Time Since Diagnosis, and Social Support Matter?HEALTH PSYCHOLOGY. Bd. 35. H. 12. 2016 S. 1329-1333
Schneeweiss, Andreas; Forster, Frank; Tesch, Hans et al.
First-line Bevacizumab-containing Therapy for HER2-negative Metastatic Breast Cancer: Final Results from a Prospective German StudyANTICANCER RESEARCH. Bd. 36. H. 3. 2016 S. 967-974
Stintzing, Sebastian; Modest, Dominik P.; Rossius, Lisa et al.
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer (FIRE-3): a post-hoc analysis of tumour dynamics in the final RAS wild-type subgroup of this randomised open-label phase 3 trialLANCET ONCOLOGY. Bd. 17. H. 10. 2016 S. 1426-1434
Kowalski, Christoph; Ferencz, Julia; Singer, Susanne et al.
Frequency of psycho-oncologic and social service counseling in cancer centers relative to center site and hospital characteristics: Findings from 879 center sites in Germany, Austria, Switzerland, and ItalyCANCER. Bd. 122. H. 22. 2016 S. 3538-3545
Priebs, J.; Nier, A.; Schattenberg, J. M. et al.
Fructose - Friend or Foe?AKTUELLE ERNAHRUNGSMEDIZIN. Bd. 41. H. 5. 2016 S. 388-401